Your browser doesn't support javascript.
loading
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
Gueye, Aliou B; Pryslawsky, Yaroslaw; Trigo, Jose M; Poulia, Nafsika; Delis, Foteini; Antoniou, Katerina; Loureiro, Michael; Laviolette, Steve R; Vemuri, Kiran; Makriyannis, Alexandros; Le Foll, Bernard.
Afiliação
  • Gueye AB; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Pryslawsky Y; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Trigo JM; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Poulia N; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Delis F; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Antoniou K; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Loureiro M; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Laviolette SR; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Vemuri K; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Makriyannis A; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
  • Le Foll B; Translational Addiction Research Laboratory (Dr Gueye, Mr Pryslawsky, Dr Trigo, and Dr Le Foll), Alcohol Research and Treatment Clinic, Addiction Medicine Services, Ambulatory Care and Structured Treatments (Dr Le Foll), and Campbell Family Mental Health Research Institute (Dr Le Foll), Centre for A
Article em En | MEDLINE | ID: mdl-27493155
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirazóis / Tabagismo / Comportamento Animal / Mesencéfalo / Redução de Peso / Comportamento Aditivo / Receptor CB1 de Canabinoide / Dispositivos para o Abandono do Uso de Tabaco / Antagonistas de Receptores de Canabinoides Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Pirazóis / Tabagismo / Comportamento Animal / Mesencéfalo / Redução de Peso / Comportamento Aditivo / Receptor CB1 de Canabinoide / Dispositivos para o Abandono do Uso de Tabaco / Antagonistas de Receptores de Canabinoides Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article